Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells

Figure 5

Critical transcription factors of Th17 cells are differentially expressed in MDS patients and controls. mRNA levels of IL-17 (a-b), RORγt (c-d), and STAT-3 (e-f) in PB and BM from L-MDS, HC, and H-MDS groups were determined by qRT-PCR.

(a)

(b)

(c)

(d)

(e)

(f)